Apeiron Investment Group Reports a $22 Million ATAI Buy

First up, Apeiron Investment Group just made a massive bet on ATAI Life Sciences $ATAI, picking up more than $22 million in stock.

The stock is up roughly 5% this morning.

Next, Carl Icahn has disclosed a 9.52% stake in JetBlue Airways $JBLU through a 13D filing.

Icahn isn’t just any investor. He’s one of the most legendary activist investors of all time.

Carl Icahn's track record speaks for itself, with high rewards from investments in companies like Apple $AAPL, Netflix $NFLX, and CVR Energy $CVI in the past.

So if history repeats itself, this 13D filing could mark the start of a major turnaround story for JBLU.

Here’s The Hot Corner, with data from February 19, 2025:

Adage Capital just bought nearly $2 million in Solid Biosciences Inc $SLDB.

And, finally, Bruker Corp’s $BRKR president and CEO just put over $1 million of his own money into the stock.